Published in Indian J Gastroenterol on March 01, 2001
A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy. Am J Gastroenterol (2013) 3.19
Bile duct obstruction due to portal biliopathy in extrahepatic portal hypertension: surgical management. Br J Surg (1998) 2.07
A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology (2007) 2.07
Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy. J Hepatol (2007) 1.88
Endoscopic sclerotherapy using absolute alcohol. Gut (1985) 1.73
Frequency and clinical profile of precore and surface hepatitis B mutants in Asian-Indian patients with chronic liver disease. Am J Gastroenterol (1996) 1.70
Blood transfusion practices in India: results of a national survey. Indian J Gastroenterol (2000) 1.70
Clinical, biochemical and histological profile of nonalcoholic steatohepatitis. Indian J Gastroenterol (2001) 1.67
P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India. Cancer (2000) 1.63
Coagulation profile and platelet function in patients with extrahepatic portal vein obstruction and non-cirrhotic portal fibrosis. J Gastroenterol Hepatol (2001) 1.52
Portal biliopathy. J Gastroenterol Hepatol (2001) 1.51
The haemodynamic response to propranolol in cirrhosis with arterial hypertension: a comparative analysis with normotensive cirrhotic patients. Aliment Pharmacol Ther (2010) 1.50
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin. J Viral Hepat (2013) 1.46
What is safe blood? J Assoc Physicians India (2000) 1.45
High seroprevalence and clinical significance of hepatitis B and C infection in hospitalized patients with alcoholic cirrhosis. J Assoc Physicians India (2002) 1.39
Recombinant interferon therapy in Indian children with HBV related chronic liver disease. Indian Pediatr (2002) 1.39
Endoscopic biliary drainage by nasobiliary drain or by stent placement in patients with acute cholangitis. Endoscopy (2005) 1.39
Inferior vena caval obstruction due to amoebic liver abscess. J Assoc Physicians India (1982) 1.33
Beneficial effects of lamivudine in hepatitis B virus-related decompensated cirrhosis. J Hepatol (2000) 1.32
Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis. J Viral Hepat (2012) 1.21
Role of HBV genotype in predicting response to lamivudine therapy in patients with chronic hepatitis B. Indian J Gastroenterol (2005) 1.20
Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther (2009) 1.19
Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study. Gut (1986) 1.16
A case report of olanzapine-induced fecal incontinence. J Clin Psychiatry (2003) 1.10
Acute pancreatitis associated with viral hepatitis: a report of six cases with review of literature. Am J Gastroenterol (1999) 1.09
The prevalence and spectrum of colonic lesions in patients with cirrhotic and noncirrhotic portal hypertension. Hepatology (1995) 1.08
Hepatitis B vaccination with or without hepatitis B immunoglobulin at birth to babies born of HBsAg-positive mothers prevents overt HBV transmission but may not prevent occult HBV infection in babies: a randomized controlled trial. J Viral Hepat (2013) 1.07
A case of hepatocellular carcinoma associated with troublesome hypoglycemia: management by cytoreduction using percutaneous ethanol injection. Am J Gastroenterol (1998) 1.07
Balloon tamponade in the management of bleeding oesophageal varices. Ann R Coll Surg Engl (1984) 1.06
Choledochal cysts--differences in children and adults. Br J Surg (1996) 1.06
Endoscopic management of liver abscesses and cysts that communicate with intrahepatic bile ducts. Endoscopy (2006) 1.05
Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and child's status. Dig Dis Sci (2006) 1.04
Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients. J Viral Hepat (1999) 1.03
NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx. Oncogene (2009) 1.01
Pattern of alcohol-related liver disease in dependent alcoholics: the Indian dimension. Br J Addict (1988) 1.01
Choledocholithiasis associated with portal biliopathy in patients with extrahepatic portal vein obstruction: management with endoscopic sphincterotomy. Gastrointest Endosc (1995) 0.99
Prevalence of hepatitis B infection within family contacts of chronic liver disease patients--does HBeAg positivity really matter? J Assoc Physicians India (2002) 0.98
Repeated endoscopic sclerotherapy for active variceal bleeding. Ann Surg (1985) 0.98
Do umbilical vein catheterization and sepsis lead to portal vein thrombosis? A prospective, clinical, and sonographic evaluation. J Pediatr Gastroenterol Nutr (1993) 0.98
Corrosive oesophageal strictures following acid ingestion: clinical profile and results of endoscopic dilatation. J Gastroenterol Hepatol (1991) 0.98
Hepatic dysfunction in patients with extrahepatic portal venous obstruction. Liver Int (2003) 0.96
Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases. QJM (2008) 0.96
Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: a preliminary report. J Gastroenterol Hepatol (2001) 0.95
Follow-up of patients after variceal eradication. A comparison of patients with cirrhosis, noncirrhotic portal fibrosis, and extrahepatic obstruction. Ann Surg (1986) 0.95
Intravariceal versus paravariceal sclerotherapy: a prospective, controlled, randomised trial. Gut (1987) 0.93
A clinico-radiological reappraisal of intestinal tuberculosis--changing profile? Gastroenterol Jpn (1986) 0.93
Hepatic manifestations in typhoid fever. Indian Pediatr (1994) 0.92
Endoscopic management of bile leaks after blunt abdominal trauma. J Gastroenterol Hepatol (2008) 0.92
Cholesterol and pigment gallstones in northern India. A prospective analysis. Dig Dis Sci (1986) 0.91
Transfusion associated hepatitis: the Indian scenario. Indian Pediatr (1997) 0.90
Early identification of haemodynamic response to pharmacotherapy is essential for primary prophylaxis of variceal bleeding in patients with 'high-risk' varices. Aliment Pharmacol Ther (2009) 0.89
Propofol sedation during endoscopy in patients with cirrhosis, and utility of psychometric tests and critical flicker frequency in assessment of recovery from sedation. Endoscopy (2011) 0.89
Absence of hemochromatosis associated Cys282Tyr HFE gene mutation and low frequency of hemochromatosis phenotype in nonalcoholic chronic liver disease patients in India. J Gastroenterol Hepatol (2004) 0.89
Hepatic visceral larva migrans: evolution of the lesion, diagnosis, and role of high-dose albendazole therapy. Am J Gastroenterol (1994) 0.89
Comparative efficacy of psychometric tests in detection of subclinical hepatic encephalopathy in nonalcoholic cirrhotics: search for a rational approach. Am J Gastroenterol (1989) 0.88
Ulcerative colitis in a North Indian hospital: current trends. J R Coll Physicians Lond (1985) 0.88
Autoimmune hepatitis in the Indian subcontinent: 7 years experience. J Gastroenterol Hepatol (2001) 0.88
Transfusion-associated hepatitis in a tertiary referral hospital in India. A prospective study. Vox Sang (1999) 0.87
Peroxisome proliferators-activated receptor γ2 Pro12Ala variant is associated with body mass index in non-alcoholic fatty liver disease patients. Hepatol Int (2010) 0.86
Is cirrhosis of the liver reversible? Indian J Pediatr (2007) 0.86
Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci (1987) 0.86
Histological subclassification of cirrhosis based on histological-haemodynamic correlation. Aliment Pharmacol Ther (2008) 0.85
Subclinical encephalopathy after portosystemic shunts in patients with non-cirrhotic portal fibrosis. Liver (1985) 0.85
Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses. J Gastroenterol Hepatol (1999) 0.84
Identification of a novel surface mutant of hepatitis B virus in a seronegative chronic liver disease patient. Virus Res (1999) 0.84
Endoscopic biliary drainage by 7 Fr or 10 Fr stent placement in patients with acute cholangitis. Dig Dis Sci (2008) 0.83
Oesophageal ulceration after sclerotherapy--a complication or an accompaniment? Endoscopy (1986) 0.82
Rabbit model of non-cirrhotic portal fibrosis with repeated immunosensitization by rabbit splenic extract. J Gastroenterol Hepatol (2002) 0.82
Gastric secretion in cirrhosis and non-cirrhotic portal fibrosis. Digestion (1988) 0.81
Polymerase chain reaction based diagnostic assay for identification of hepatitis B virus. Indian J Med Res (1992) 0.80
Serum hepatitis B surface antigen levels correlate with high serum HBV DNA levels in patients with chronic hepatitis B: a cross-sectional study. Indian J Med Microbiol (2012) 0.80
Increased regulatory T cells and impaired functions of circulating CD8 T lymphocytes is associated with viral persistence in Hepatitis B virus-positive newborns. J Viral Hepat (2013) 0.80
Studies on TAQ1 polymorphism in the 3'untranslated region of IL-12P40 gene in HCV patients infected predominantly with genotype 3. J Med Virol (2006) 0.80
Feasibility spectrum for Doppler flowmetry of splanchnic vessels. In normal and cirrhotic populations. J Ultrasound Med (1990) 0.79
Possible HLA influence in governing susceptibility to non-cirrhotic portal fibrosis. Tissue Antigens (1987) 0.79
Diaphragm disease of duodenum following long-term NSAIDs use: endoscopic management. Indian J Gastroenterol (2004) 0.79
Amoebic liver abscess in a North Indian hospital--current trends. Br J Clin Pract (1987) 0.79
Prevention of first variceal bleed: an appraisal of current therapies. Am J Gastroenterol (1998) 0.79
Low-dose recombinant interferon therapy in anti-HBe-positive chronic hepatitis B in Asian Indians. J Gastroenterol Hepatol (1998) 0.79
Prevalence of hepatitis GB virus C/hepatitis G virus infection in blood donors in India. J Assoc Physicians India (2000) 0.79
Histological comparison of chronic hepatitis B and C in an Indian population. Trop Gastroenterol (2000) 0.78
Carcinoid tumour of ampulla of Vater associated with viscero-cutaneous neurofibromatosis. Postgrad Med J (1983) 0.78
Systematic review: combination therapies for treatment-naïve chronic hepatitis B. Aliment Pharmacol Ther (2008) 0.78
Biliary lipid composition in patients with non-cirrhotic portal fibrosis--a comparison with compensated cirrhosis of the liver. Liver (1987) 0.78
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3. J Viral Hepat (2012) 0.78
Association of IL-18 promoter polymorphism with liver disease severity in HCV-infected patients. Hepatol Int (2009) 0.78
Cholestatic liver injury due to ibuprofen. Indian J Gastroenterol (2005) 0.78
Hepatic Sarcoidosis: Clinico-pathological characterization of symptomatic cases. Acta Gastroenterol Belg (2015) 0.77
Measuring hepatic functional reserve using MEGX: still a mirage! Indian J Gastroenterol (2008) 0.77
Profile of asymptomatic chronic HBV infection in India. Indian J Med Res (2002) 0.77
Do chillies influence healing of duodenal ulcer? Br Med J (Clin Res Ed) (1984) 0.77
Noncompressive myelopathy after lienorenal shunt in a patient with noncirrhotic portal fibrosis. Am J Gastroenterol (1983) 0.77
Characterization of peripheral blood lymphocytes in patients with non-cirrhotic portal fibrosis: a comparison with cirrhotics and healthy controls. J Gastroenterol Hepatol (1991) 0.77
Relevance of hepatitis B surface antigen levels in patients with chronic hepatitis B during 5 year of tenofovir treatment. J Viral Hepat (2013) 0.77
Clinical trial on the effect of domperidone on non-ulcer dyspepsia. Indian J Med Res (1986) 0.76
Fine needle aspiration cytologic appearance of inflammatory pseudotumor of the liver. A case report. Acta Cytol (1999) 0.76
Beneficial influence of an indigenous low-iron diet on serum indicators of iron status in patients with chronic liver disease. Br J Nutr (2000) 0.76